“
TL;DR
This qualitative study used key-informant interviews with 11 national and state program managers to identify factors affecting the nationwide rollout of the Pneumococcal Conjugate Vaccine in India during the COVID-19 pandemic.
Health Services Insights · 9 authors, 3 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This qualitative study used key-informant interviews with 11 national and state program managers to identify factors affecting the nationwide rollout of the Pneumococcal Conjugate Vaccine in India during the COVID-19 pandemic.
A qualitative study involving 11 key-informant interviews with national program managers and state technical officers was conducted to assess enablers and barriers to scaling up the Pneumococcal Conjugate Vaccine in India during the COVID-19 pandemic. Using thematic analysis based on a modified WHO framework, the study found key enablers included social acceptance of the vaccine, intensive communication, a robust vaccine supply-chain system, ample cold-chain space, and strong political commitment. The findings provide programmatic insights for improving future vaccine introductions during public health emergencies.